Drug Profile
Herpes simplex vaccine - Ivanovski Institute of Virology/Vitafarma
Alternative Names: VITAHERPAVACLatest Information Update: 30 Sep 2015
Price :
$50
*
At a glance
- Originator Ivanovsky Institute of Virology; Vitafarma
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Herpes simplex virus infections